Document Classification

Section Type: RESULTS

Text: Patients on the 6-month regimen converted more rapidly than patients on the 9-month regimen (94. 6 % compared with 89. 9 % after 16 weeks of therapy, with a difference of 4. 7 % [95 % CI, 0. 7 % to 8. 7 %]) ; had similar rates of adverse drug reactions (7. 7 % compared with 6. 4 %, with a difference of 1. 3 % [95 % CI, 0. 0 % to 4. 6 %]) ; had lower noncompliance rates (16. 8 % compared with 29. 2 %, with a difference of 12. 4 % [95 % CI, 6. 8 % to 18. 0 %]) ; and had similar relapse rates 96 weeks after completing therapy (3. 5 % compared with 2. 8 %, with a difference of 0. 7 % [95 % CI, 0. 0 % to 3. 9 %]).